(5S,8R)-HBV-IN-10

Modify Date: 2025-08-25 00:44:44

(5S,8R)-HBV-IN-10 Structure
(5S,8R)-HBV-IN-10 structure
Common Name (5S,8R)-HBV-IN-10
CAS Number 2716907-15-0 Molecular Weight 433.48
Density N/A Boiling Point N/A
Molecular Formula C23H24FN7O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (5S,8R)-HBV-IN-10


(5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1].

 Names

Name (5S,8R)-HBV-IN-10

 (5S,8R)-HBV-IN-10 Biological Activity

Description (5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1].
Related Catalog
References

[1]. Azabicyclo compound as hepatitis b surface antigen inhibitor. WO2021204252A1.

 Chemical & Physical Properties

Molecular Formula C23H24FN7O
Molecular Weight 433.48
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

(5S,8R)-HBV-IN-10 suppliers

(5S,8R)-HBV-IN-10 price

Related Compounds: More...
HBV-IN-10
2716907-16-1
[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] N-(2-chloroethyl)-N-nitroso-carbamate
54025-35-3
[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] cyclohexanecarboxylate
20592-38-5
(5S,8R)-5-allyl-2,2,3,3,10,10,11,11-octamethyl-8-(4-methylpentyl)-4,9-dioxa-3,10-disiladodecane
875570-75-5
(5S,8R,9S,10S,13S,14S,17S)-17-ethynyl-3,3-difluoro-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
2448-69-3
(5S,8R,9S,10S,13S,14S,17S)-3-(1-cyclopenta-2,4-dienylidene)-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
6952-09-6
[(5S,8R,9S,10S,13S,14S,17S)-13-methyl-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
33767-87-2
(5S,8R)-4,4,8-trimethyl-1-oxaspiro[4.5]dec-6-en-2-one
679396-13-5
(5S,8R,9R,10S)-(+)-(13E)-labd-13-ene-8,15-diol
3649-91-0
3-(5-Bromo-3-pyridinyl)-6-(2-chlorophenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
951928-88-4
(4E)-5-(3-chlorophenyl)-1-[3-(dimethylamino)propyl]-4-[hydroxy(1,3,5-trimethyl-1H-pyrazol-4-yl)methylidene]pyrrolidine-2,3-dione
1010869-28-9
3-(1H-indol-3-yl)-1-[4-(pyridin-4-ylcarbonyl)piperazin-1-yl]propan-1-one
951930-12-4
N-[(2Z)-5-methoxy[1,3]thiazolo[4,5-f]quinolin-2(1H)-ylidene]-4-(propan-2-yloxy)benzamide
951980-58-8
1-(3-(2-methoxyphenyl)-5-(quinoxalin-6-yl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone
946361-34-8
2-[3-(2-Fluorophenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl]quinoline
951931-17-2
4-hydroxy-N-(pyridin-4-yl)quinoline-3-carboxamide
873050-70-5
3-(4-chlorophenyl)-9-(2-methoxyethyl)-2-(trifluoromethyl)-9,10-dihydrochromeno[8,7-e][1,3]oxazin-4(8H)-one
951936-50-8
4-(Methoxymethyl)-N-phenyl-1-(2-(thiophen-2-yl)ethyl)piperidin-4-amine
72996-73-7
4-{[4-(6-methoxy-2-oxo-2H-chromen-3-yl)phenoxy]acetyl}piperazine-1-carbaldehyde
951937-41-0